Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-Marketing Surveillance of Lenvima in Unresectable Thyroid Cancer (Japan, All-Case Study)
jRCT1080222856Recruiting
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lenvatinib in thyroid cancer, sponsored by Eisai Co., Ltd. Started May 2015; status: recruiting.
02
Drugs
lenvatinib
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on jRCT1080222856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222856.